The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

Journal of Interferon and Cytokine Research

Volumn 16, Issue 7, 1996, Pages 489-499

  Blatt, Lawrence M ^a   Davis, Janice M ^a   Klein, Susan B ^b   Taylor, Milton W ^b  

^a AMGEN INC   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; AMINO ACID; ANTIBODY; ARGININE; BETA 2 MICROGLOBULIN; CONSENSUS INTERFERON; CYTOKINE; DNA; EPITOPE; GENE PRODUCT; HLA ANTIGEN; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; METALLOTHIONEIN; METHIONINE; NEOPTERIN; PROTEIN; PROTEIN TYROSINE KINASE; SYNTHETASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BINDING SITE; CIRCULAR DICHROISM; DRUG ACTIVITY; EPITOPE MAPPING; GENE; GENE INDUCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOELECTRIC FOCUSING; MALIGNANT NEOPLASTIC DISEASE; MUTATION; NATURAL KILLER CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 0029833999     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.489     Document Type: Review

References (64)

1. PESTKA, S. (1986). Interferon from 1981 to 1986. Methods Enzymol. 119, 3-14.
2. DIAZ, M.O., POMYKALA, H.M., BOHLANDER, S.K., MALITEPE, E., MALIK, K., BROWNSTEIN, B., and OLOPADE, O.I. (1994). Structure of the human type I Interferon gene cluster determined from a YAC clone contig. Genomics 22, 540-552.
3. SENDA, T., SHIMAZU, T., MATSUDA, S., KAWANO, G., SHIMIZU, H., NAKAMURA, K.T., and MITSUI, Y. (1992). Three dimensional crystal structure of recombinant murine interferon-β. EMBO J. 11, 3193-3201.
4. PFEFFER, L.M., and STRULOVICI, B. (1992). Transmembrane secondary messengers for IFN-α/β. In: Interferon. Principles and Medical Applications. S. Baron, D.H. Coopenhaver, F. Dianzani, W.R. Fleischmann Jr., T.K. Hughes Jr., G. R. Kimpel, D.W. Niesel, G.J. Stanton, and S. K. Tyring, eds. Galveston, TX: The University of Texas Medical Branch at Galveston, pp. 151-160.
5. JOHNSON, H.M., BAZER, F.W., SZENTE, B.E., and JARPE, M.A. (1994). How interferons fight disease. Sci. Am. 270:68-75.
6. PESTKA, S.S., LANGER, J.A., ZOON, K.C., and SAMUEL, C.E. (1987). Interferons and their actions. Annu. Rev. Biochem. 56:727.
7. CHEBATH, J. and REVEL, M. (1992). The 2-5 A system: 2-5 A synthetase, isospecies and functions. In: Interferon. Principles and Medical Applications. S. Baron, D.H. Coopenhaver, F. Dianzani, W.R. Jr. Fleischmann, T.K. Jr. Hughes, G.R. Kimpel, D.W. Niesel, G.J. Stanton, and S.K. Tyring, eds. Galveston, TX: The University of Texas Medical Branch at Galveston, pp. 225-236.
8. SAMUEL, C. (1992). The RNA-dependent P1/elF-2α protein kinase. In: Interferon. Principles and Medical Applications. S. Baron, D.H. Coopenhaver, F. Dianzani, W.R. Fleischmann Jr., T.K. Hughes Jr., G.R. Kimpel, D.W. Niesel, G.J. Stanton, and S.K. Tyring, eds. Galveston, TX: The University of Texas Medical Branch at Galveston, pp. 237-250.
9. HORISBERGER, M.A. (1992). MX protein: function and Mechanism of Action. In: Interferon. Principles and Medical Applications. S. Baron, D.H. Coopenhaver, F. Dianzani, W.R. Fleischmann Jr., T.K. Hughes Jr., G.R. Kimpel, D.W. Niesel, G.J. Stanton, and S.K. Tyring, eds. Galveston, TX: The University of Texas Medical Branch at Galveston, pp. 215-224.
10. FISH, E.N., BANERJEE, K., and STEBBING, N. (1989). The role of three domains in the biological activity of human interferon-α. J. Interferon Res. 9, 97-114.
11. OZES, O.N., REITER, Z., KELIN, S., BLATT, L.M., and TAYLOR, M.W. (1992). A comparison of interferon-Con1 with natural recombinant interferon-α: antiviral, antiproliferative and natural killer inducing activities. J. Interferon Res. 12, 55-59.
12. RUBINSTEIN, M. (1987). Multiple interferon subtypes; the phenomenon and its relevance. J. Interferon Res. 7, 545-551.
13. LEE, S.H., KELLEY, S., CHIU, H., and STEBBING, N. (1982). Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes. Cancer Res. 42, 1312-1316.
14. ALTON, K., STABINSKY, Y., RICHARDS, R., FERGUSON, B., GOLDSTEIN, L., ALTROCK, B., MILLER, L., and STEBBING, N. (1983). Production, characterization and biological effects of recombinant DNA derived human IFN-α and IFN-γ analogs. In: The Biology of the Interferon System. E. De Maeyer and H. Schellekens, eds. Amsterdam: Elsevier, pp. 119-128.
15. BEN-BASSAT, A., BAUER, K., CHANG, S.-Y., MYAMBO, K., BOOSMAN, A., and CHANG, S. (1987). Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure. J. Bacteriol. 169, 751-757.
16. α-acetylated. Protein Expression Purification 4, 499-502.
17. KLEIN, M.L., BARTLEY, T.D., LAI, P.-H., and LU, H.S. (1988). Structural characterization of recombinant consensus interferon-α. J. Chromatog. 454, 205-216.
18. KLEIN, M.L., BARTLEY, T.D., DAVIS, J.M., WHITELEY, D.W., and LU, H.S. (1990). Isolation and structural characterization of three isoforms of recombinant consensus alpha interferon. Arch. Biochem. Biophys. 276, 531-537.
19. HU, C.J., OZES, O.N., KLEIN, S.B., BLATT, L.M., and TAYLOR, M.W. (1995). A comparison of the in vitro host range of recombinant met-interferon-Con1, interferon-α2a, and interferon-β. J. Interferon Cytokine Res. 15, 231-234.
20. FISH, E.N., BANERJEE, K., LEVINE, H.L., and STEBBING, N. (1986). Antiherpetic effects of a human alpha interferon analog, interferon-alpha-Con-1 in hamsters. Antimicrob. Agents Chemother. 30, 52-56.
21. MOREHEAD, H., JOHNSTON, P.D., and WETZEL, R. (1984). Roles of the 29-138 disulfide bond of subtype A of human alpha interferon in its antiviral activity and conformational stability. Biochemistry 23, 2500-2507.
22. HARVEY, W., SROUR, E.F., TURNER, R., CAREY, R., MAZE, R., STARRETT, B., KANAGALA, R., PEREIRA, D., MERCHANT, P., TAYLOR, M.W., and JANSEN, J. (1991). Characterization of a new cell line (Esko1) resembling hairy cell leukemia: a model for oncogene regulation and late B-cell differentiation. Leukemia Res. 15, 733-744.
23. REITER, Z., OZES, O.N., BLATT, L.M., STURZL, M., and TAYLOR, M.W. (1992). A possible role for interferon-alpha and activated natural killer cells in remission of AIDS-related Kaposi's sarcoma: in vitro studies. J. AIDS 5, 469-476.
24. TILG, H., MIER, J.W., VOGEL, W., AULITZKY, W.E., WIEDERMANN, C.J., VANNIER, E., HUBER, C., and DINARELLO, C.A. (1993). Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol. 150, 4687-4692.
25. HUANG, Y., BLATT, L.M., and TAYLOR, M.W. (1995). Type 1 interferon as an anti-inflammatory: inhibition of lipopolysaccharide induced interleukin-1β and induction of interleukin-1 receptor antagonist. J Interferon Cytokine Res. 15, 317-321.
26. KLEIN, S.B., BLATT, L.M., and TAYLOR, M.W. (1993). Consensus interferon induces peak mRNA accumulation at lower concentrations that interferon-α2a. J. Interferon Res. 13, 341-347.
27. KLEIN, S.B., BLATT, L.M., and TAYLOR, M.W. (1996). Cell surface characteristics correlate with consensus type I interferon enhanced activity. J. Interferon Cytokine Res. 16, 1-6.
28. UZE, G., LUTFALLA, G., and GRESSER, I. (1990). Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its complementary DNA. Cell 60, 225-234.
29. COLAMONICI, O.R., PFEFFER, L.M., D'ALESSANDRO, F., PLATANIAS, L.C., GREGORY, S.A., ROSOLEN, A., NORDAN, R., CRUCIANI, R.A., and DIAZ, M.O. (1992). Multichain structure of the IFN-alpha receptor on hematopoietic cells. J. Immunol. 148, 2126-2132.
30. BRANCA, A.A., and BAGLIONI, C. (1981). Evidence that types I and II interferons have different receptors. Nature 294, 768-770.
31. HANNIGAN, G., and WILLIAMS, B.R. (1986). Transcriptional regulation of interferon-responsive genes is closely linked to interferon receptor occupancy. EMBO J. 5, 1607-1613.
32. CEBRIAN, M., YAGÜE, E., DE LANDÁZURI, M.O., RODÌGUEZ-MOYA, M., FRESNO, M., PEZZI, N., LLAMAZARES, S., and SÀNCHEZ-MADRID, F. (1987). Different functional sites on rIFN-α2 and their relation to the cellular receptor binding site. J. Immunol. 138, 484-490.
33. MYERS, A.C., KOVACH, J.S., and VUK-PAVLOVIC, S. (1987). Binding, internalization, and intracellular processing of protein ligands: derivation of rate constants by computer modeling. J. Biol. Chem 262, 6494-6499.
34. PFEFFER, L.M., STEBBING, N., and DONNER, D.B. (1987). Cytoskeletal association of human alpha-interferon-receptor complexes in interferon-sensitive and -resistant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 84, 3249-3253.
35. SCHWABE, M., PRINCLER, G.L., and FALTYNEK, C.R. (1988). Characterization of the human type I interferon receptor by ligand blotting. Eur. J. Immunol. 18, 2009-2014.
36. FISH, E.N. (1992). Definition of receptor binding domains in interferon-alpha. J. Interferon Res. 12, 257-266.
37. MOUCHEL-VIELH, E., LUTFALLA, G., MOGENSEN, K.E., and UZE, G. (1992). Specific antiviral activities of the human interferons are determined at the level of receptor (IFNAR) structure. FEBS Lett. 313, 255-259.
38. OVERALL, M.L., CHAMBERS, P., and HERTZOG, P.J. (1992). Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells. J. Interferon Res. 12, 281-288.
39. BENOIT, P., MAGUIRE, D., PLAVEC, I., KOCHER, H., TOVEY, M., and MEYER, F. (1993). A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-α, IFN-β and IFN-ω. J. Immunol. 150, 707-716.
40. COLAMONICI, O.R., and DOMANSKI, P. (1993). Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J. Biol. Chem. 268, 10895-10899.
41. NOVICK, D., COHEN, B., and RUBINSTEIN, M. (1994). The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77, 391-400.
42. UZÉ, G., LUTFALLA, G., and MOGENSEN, K. (1995). α and β interferons and their receptor and their friends and relations. J. Interferon Cytokine Res. 15, 3-26.
43. DOMANSKI, P., WITTE, M., KELLUM, M., RUBINSTEIN, M., KACKETT, R., PITHA, P., and COLAMONICI O.R. (1995). Cloning and expression of a long form of the β subunit of the interferon AB receptor that is required for signaling. J. Biol. Chem. 270, 21606-21611.
44. GHISLAIN, J., SUSSMAN, G., GOELZ, S., LING, L.E., and FISH, E.N. (1995). Configuration of the interferon α/β receptor complex determines the context of the biological response. J. Biol. Chem. 270, 21785-21792.
45. EVINGER, M., MAEDA, S., and PESTKA, S. (1981). Recombinant human leukocyte interferon produced in bacteria has antiproliferative activity. J. Biol. Chem. 256, 2113-2114.
46. EPSTEIN, C.J., McMANUS, N.H., EPSTEIN, L.B., BRANCA, A.A., D'ALESSANDRO, S.B., and BAGLIONI, C. (1982). Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon receptor. Biochem. Biophys. Res. Commun. 107, 1060-1066.
47. ZOON, K.C., ZUR NEDDEN, D., and ARNHEITER, H. (1982). Specific binding of human alpha interferon to a high affinity cell surface binding site on bovine kidney cells. J. Biol. Chem. 257, 4695-4697.
48. BERMAN, B., and VILCEK, J. (1974). Cellular binding characteristics of human interferon. Virology 57, 378-386.
49. YONEHARA, S., YONEHARA-TAKAHASHI, M., and ISHII, A. (1983). Binding of human interferon to cells of different sensitivities: studies with internally radiolabeled interferon retaining full biological activity. J. Virol. 45, 1168-1171.
50. AGUET, M. (1991). Molecular cloning of interferon receptors: a short review. Br. J. Haematol. 79 (Suppl 1), 6-8.
51. KORN, A.P., ROSE, D.R., and FISH, E.N. (1994). Three-dimensional model of a human interferon-α consensus sequence J. Interferon Res. 14, 1-9.
52. LYDON, N.B., FAVRE, C., BOVE, S., NEYRET, O., BENUREAU, S., LEVINE, A.M., SEELIG, G.F., NAGABHUSHAN, T.L., and TROTTA, P.P. (1985). Immunochemical mapping of alpha-2-interferon. Biochemistry 24, 4131-4141.
53. VON GABAIN, A., OHLSSON, A., HOLMGREN, M., JOSEPHSSON, E., ALKAN, S., and LUNDGREN, E. (1987). Differential structures and activities of three IFN-α2 variants departing at only two amino acid positions. In: Biology of the Interferon System. K. Cantell and H. Schellekens, eds. Dordrecht: Martinus Nijhoff Pubs., pp. 11-18.
54. OVERALL, M.L., and HERTZOG, P.J. (1992). Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha-4: subtype reactivity, neutralization of biological activities and epitope analysis. Mol. Immunol. 29, 391-399.
55. ARNHEITER, H., OHNO, M., SMITH, M., GUTTE, B., and ZOON, K.C. (1983). Orientation of a human leukocyte interferon molecule on its cell surface receptor:carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment. Proc. Natl. Acad. Sci. USA 80, 2539-2543.
56. DANILKOVICH, A.V., FREZE, K.V., SHEVALIER, A.F., SAMUKOV, V.V., KIRKIN, A.F., and GUSEV, M.V. (1991). Synthetic peptide with antiproliferative activity: a short C-terminal fragment of the human interferon-alpha-2 molecule. Immunol. Lett. 31, 15-20.
57. EICHMANN, E., MAJAROV, V.A., KOZHICH, A.T., NOLL, F., and ZAV'YALOV, V.P. (1990). Biological activities of synthetic peptides of the sequence of human interferon-alpha. Immunol. Lett. 24, 233-236.
58. CAMBLE, R., FETTER, N.N., TRUEMAN, P., NEWTON, C.R., CARR, F.J., HOCKNEY, R.C., MOORE, V.E., GREENE, A.R., HOLLAND, D., and EDGE, M.D. (1986). Functionally important conserved amino-acids in interferon-alpha-2 identified with analogs produced from synthetic genes. Biochem. Biophys. Res. Commun. 134, 1404-1411.
59. CHEETHAM, B.F., McINNES, B., MANTAMADIOTIS, T., MURRAY, P.J., ALIN, P., BOURKE, P., LINNANE, A.W., and TYMMS, M.J. (1991). Structure-function studies of human interferon-alpha: enhanced activity on human and murine cells. Antiviral Res. 15, 27-40.
60. TYMMS, M.J., McINNES, B., WAINE, G.J., CHEETHAM, B.F., and LINNANE, A.W. (1989). Functional significance of amino acid residues within conserved hydrophilic regions in human interferons-alpha. Antiviral Res. 12, 37-48.
61. BALKWILL, R.F., GOLDSTEIN, L., and STEBBING, N. (1985). Differential action of six human interferons against two human carcinomas growing in nude mice. Int. J. Cancer 35, 613-617.
62. TROUSDALE, M.D., ROBIN, J.B., and STEBBING, N. (1987). Reevaluation of human alpha interferon against herpesvirus infection of the rabbit eye. Curr. Eye Res. 6, 269-272.
63. GENG, Y., YU, D., BLATT, L.M., and TAYLOR M.W. (1995). Tumor suppressor activity of the human consensus type I interferon gene. Cytokines Mol. Then 1, 289-300.
64. ZHANG, J.F., HU, C., GENG, Y., BLATT, L.M., and TAYLOR, M.W. (1996). Gene therapy with an adeno-associated virus carrying an enterferon gene results in tumor growth suppression and regression. Cancer Gene Ther. 3, 31-38.